Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?

2006 ◽  
Vol 2 (7) ◽  
pp. 346-347 ◽  
Author(s):  
Arthur Kavanaugh
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Early Rheumatoid Arthritis ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Inhibitors ◽  
Necrosis Factor

scholarly journals Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

2011 ◽  
Vol 64 (1) ◽  
pp. 42-52 ◽  
Author(s):  
Lotta Ljung ◽  
Julia F. Simard ◽  
Lennart Jacobsson ◽  
Solbritt Rantapää-Dahlqvist ◽  
Johan Askling ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Early Rheumatoid Arthritis ◽  
Acute Coronary Syndromes ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Inhibitors ◽  
Coronary Syndromes ◽  
Necrosis Factor

The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis

2012 ◽  
Vol 18 (11) ◽  
pp. 1502-1511 ◽  
Author(s):  
Mike J.L. Peters ◽  
Alper M. van Sijl ◽  
Alexandre E. Voskuyl ◽  
Naveed Sattar ◽  
Yvo M. Smulders ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cardiovascular Risk ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Inhibitors ◽  
Necrosis Factor

scholarly journals Delay in imaging versus clinical response: A rationale for prolonged treatment with anti–tumor necrosis factor medication in early rheumatoid arthritis

2007 ◽  
Vol 57 (8) ◽  
pp. 1564-1567 ◽  
Author(s):  
Richard J. Wakefield ◽  
Jane E. Freeston ◽  
Elizabeth M. A. Hensor ◽  
Domini Bryer ◽  
Mark A. Quinn ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Clinical Response ◽  
Early Rheumatoid Arthritis ◽  
Tumor Necrosis ◽  
Prolonged Treatment ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document